Back to Industry News
Medtech
Forbes Spotlights Pockit Diagnostics' Portable Medtech Innovation
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Forbes
Photo by Annie Spratt on Unsplash
Stay updated on stories like this
Key takeaways
- Gonzalo Ladreda, CEO and co-founder of Pockit Diagnostics, has been named to Forbes' 2023 30 Under 30 Europe list in the Science & Healthcare category
- Ladreda is recognized for his development of a portable, rapid blood test designed to expedite stroke diagnosis by utilizing blood biomarkers, potentially reducing reliance on immediate hospital brain scans
- Pockit Diagnostics, a Cambridge-based medtech startup, has secured $3
Gonzalo Ladreda, CEO and co-founder of Pockit Diagnostics, has been named to Forbes' 2023 30 Under 30 Europe list in the Science & Healthcare category. Ladreda is recognized for his development of a portable, rapid blood test designed to expedite stroke diagnosis by utilizing blood biomarkers, potentially reducing reliance on immediate hospital brain scans.
Pockit Diagnostics, a Cambridge-based medtech startup, has secured $3.7 million in public and private funding to further advance its diagnostic technology. The company anticipates commencing clinical trials with patients later this year.
Related Topics
medtechPockit Diagnosticsportable diagnosticshealthcare innovation30 Under 30ForbesGonzalo Ladreda
Never miss stories like this